Three radiation oncologists describe living through cyberattacks that paralyzed their clinics. They urge all clinicians to make plans to keep services running so that patients don t miss out on treatment.
Program details on keynote addresses, distinguished awards and late-breaking abstracts are being provided by program planners of the American Society for Radiation Oncology (ASTRO) Annual Meeting, set for October 23-26, in San Antonio, TX.
Stereotactic body radiotherapy (SBRT) significantly improved progression- free survival for patients with oligoprogressive, metastatic lung cancer but not breast cancer.
A preliminary study suggests high-dose radiation therapy may stall tumor growth in patients with advanced lung cancer who are not fully responding to drug therapies.